Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.

导出 OA

翻译打印收藏纠错

作者： Anat,Schwartz ^[1] ; Omer,Nir ^[2] ; Shlomi,Toussia-Cohen ^[2] ; Leah,Leibovich ^[3] ; Tzipora,Strauss ^[3] ; Keren,Asraf ^[4] ; Ram,Doolman ^[4] ; Sivan,Sharabi ^[4] ; Carmit,Cohen ^[5] ; Einav Gal,Levin ^[5] ; Yaniv,Lustig ^[6] ; Gili,Regev-Yochay ^[5] ; Yoav,Yinon ^[7]

作者单位： Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer 52621, Israel. Electronic address: anatsch3@gmail.com. ^[1] Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer 52621, Israel. ^[2] Department of Neonatology, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[3] Automated Mega Laboratory, Sheba Medical Center, Tel Hashomer, Israel. ^[4] Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Infection Prevention and Control Unit, Sheba Medical Center, Tel Hashomer, Israel. ^[5] Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel Hashomer, Israel. ^[6] Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[7]